266 related articles for article (PubMed ID: 11839592)
1. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment.
Ohno-Matsui K; Hirose A; Yamamoto S; Saikia J; Okamoto N; Gehlbach P; Duh EJ; Hackett S; Chang M; Bok D; Zack DJ; Campochiaro PA
Am J Pathol; 2002 Feb; 160(2):711-9. PubMed ID: 11839592
[TBL] [Abstract][Full Text] [Related]
2. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
Tobe T; Okamoto N; Vinores MA; Derevjanik NL; Vinores SA; Zack DJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):180-8. PubMed ID: 9430560
[TBL] [Abstract][Full Text] [Related]
3. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
Takahashi K; Saishin Y; Saishin Y; Silva RL; Oshima Y; Oshima S; Melia M; Paszkiet B; Zerby D; Kadan MJ; Liau G; Kaleko M; Connelly S; Luo T; Campochiaro PA
FASEB J; 2003 May; 17(8):896-8. PubMed ID: 12670875
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice.
Vinores SA; Derevjanik NL; Vinores MA; Okamoto N; Campochiaro PA
Adv Exp Med Biol; 2000; 476():129-38. PubMed ID: 10949661
[TBL] [Abstract][Full Text] [Related]
5. Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor.
Miki K; Miki A; Matsuoka M; Muramatsu D; Hackett SF; Campochiaro PA
Ophthalmology; 2009 Sep; 116(9):1748-54. PubMed ID: 19643496
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization.
Okamoto N; Tobe T; Hackett SF; Ozaki H; Vinores MA; LaRochelle W; Zack DJ; Campochiaro PA
Am J Pathol; 1997 Jul; 151(1):281-91. PubMed ID: 9212753
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.
Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E
Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233
[TBL] [Abstract][Full Text] [Related]
8. Topical nepafenac inhibits ocular neovascularization.
Takahashi K; Saishin Y; Saishin Y; Mori K; Ando A; Yamamoto S; Oshima Y; Nambu H; Melia MB; Bingaman DP; Campochiaro PA
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):409-15. PubMed ID: 12506103
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor.
Oshima Y; Deering T; Oshima S; Nambu H; Reddy PS; Kaleko M; Connelly S; Hackett SF; Campochiaro PA
J Cell Physiol; 2004 Jun; 199(3):412-7. PubMed ID: 15095288
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization.
Spilsbury K; Garrett KL; Shen WY; Constable IJ; Rakoczy PE
Am J Pathol; 2000 Jul; 157(1):135-44. PubMed ID: 10880384
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization.
Oshima Y; Oshima S; Nambu H; Kachi S; Hackett SF; Melia M; Kaleko M; Connelly S; Esumi N; Zack DJ; Campochiaro PA
J Cell Physiol; 2004 Dec; 201(3):393-400. PubMed ID: 15389527
[TBL] [Abstract][Full Text] [Related]
12. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.
Ishida S; Usui T; Yamashiro K; Kaji Y; Amano S; Ogura Y; Hida T; Oguchi Y; Ambati J; Miller JW; Gragoudas ES; Ng YS; D'Amore PA; Shima DT; Adamis AP
J Exp Med; 2003 Aug; 198(3):483-9. PubMed ID: 12900522
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of integrin α5β1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model.
Sui A; Zhong Y; Demetriades AM; Lu Q; Cai Y; Gao Y; Zhu Y; Shen X; Xie B
Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):951-961. PubMed ID: 29502235
[TBL] [Abstract][Full Text] [Related]
14. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
[TBL] [Abstract][Full Text] [Related]
15. Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy.
Donahue ML; Phelps DL; Watkins RH; LoMonaco MB; Horowitz S
Curr Eye Res; 1996 Feb; 15(2):175-84. PubMed ID: 8670726
[TBL] [Abstract][Full Text] [Related]
16. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Pierce EA; Foley ED; Smith LE
Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
[TBL] [Abstract][Full Text] [Related]
17. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Lima e Silva R; Hylton D; Rudge JS; Wiegand SJ; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):241-8. PubMed ID: 12652651
[TBL] [Abstract][Full Text] [Related]
18. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
van Eeden PE; Tee LB; Lukehurst S; Lai CM; Rakoczy EP; Beazley LD; Dunlop SA
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4638-45. PubMed ID: 17003462
[TBL] [Abstract][Full Text] [Related]
19. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat.
Dorey CK; Aouididi S; Reynaud X; Dvorak HF; Brown LF
Arch Ophthalmol; 1996 Oct; 114(10):1210-7. PubMed ID: 8859080
[TBL] [Abstract][Full Text] [Related]
20. Insulin-induced vascular endothelial growth factor expression in retina.
Lu M; Amano S; Miyamoto K; Garland R; Keough K; Qin W; Adamis AP
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3281-6. PubMed ID: 10586954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
